Navigation Links
Cell skeleton may hold key to overcoming drug resistance in cancer
Date:10/4/2007

Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

A team of scientists at Childrens Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cells cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs, said Associate Professor Kavallaris.

This is the first scientific evidence for the broader implications of abnormal expression of this protein.

We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs, said Associate Professor Kavallaris.


'/>"/>

Contact: Pearly Harumal
pharumal@ccia.org.au
029-962-5663
Research Australia
Source:Eurekalert

Related medicine news :

1. Skeleton May Sustain Damage Due To Use Of Anti-Depressants
2. UF scientists Throw light on the origin of vertebrate skeleton
3. Culling followed by checking: Government to audit the documents, to ascertain no skeletons in the closet!
4. Discovery Of Human Skeletons Could Unfold Facts About By-Gone Ages
5. Overcoming actively may help in breast cancer
6. Overcoming Chronic Fatigue
7. Anorexia - Overcoming Hunger Pangs Isn’t Just About Will Powe
8. Anonymity Helps In Overcoming Inhibitions During Online Counseling
9. Mans Best Friend Could Be a Useful Companion in Overcoming Depression
10. New antibiotic already developing resistance
11. Adopting Easier Methods To Screen Insulin Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... it has been selected by Tidelands Health, a three hospital system in South ... be constantly on the lookout for technology that enhances communication, drives workflow efficiencies ...
(Date:5/3/2016)... ... May 03, 2016 , ... Boston Children’s Hospital today announced its new pediatric ... practice tricky or rare procedures in an environment that looks and feels real. , ... available to inventors and “hackers” to develop and test new devices or software platforms ...
(Date:5/3/2016)... ... May 03, 2016 , ... Each year, about 800,000 people ... death across the United States and account for one death every four minutes. ... are permanently disabled. HCR ManorCare is launching a video series called “Your Brain,” in ...
(Date:5/3/2016)... Los Angeles, CA (PRWEB) , ... May 03, 2016 , ... ... Massage Chair with its user friendly Samsung tablet and exclusive Smart Application. The ... truly unbeatable massage. Starting each massage with a customized user profile and specialized massage ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... healthcare industry, announced today that Legacy Health is expanding its use of Intrigma’s ... after a highly successful initial proof of concept. The Portland, Oregon based health ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... 2, 2016 Kalorama Information noted the 5 ... market in a recent white paper.  The healthcare market ... usage, a growing market are among the top drivers ... report EMR 2016: The Market for Electronic ... complete study of the EMR industry, and the report ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
(Date:4/29/2016)... New Jersey , April 29, 2016 /PRNewswire/ ... Software Suite for Life Sciences, Product Development Capabilities ... Global Life Science Customer Base . ... solutions provider, today announced the acquisition of Skura ... a global leader in adaptive sales enablement technology ...
Breaking Medicine Technology: